Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Operating Expenses (2025)

Historic Operating Expenses for RenovoRx (RNXT) over the last 1 years, with Q3 2025 value amounting to $3.4 million.

  • RenovoRx's Operating Expenses changed N/A to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $11.0 million for FY2024, which is N/A changed from last year.
  • RenovoRx's Operating Expenses amounted to $3.4 million in Q3 2025.
  • Over the past 5 years, RenovoRx's Operating Expenses peaked at $3.4 million during Q3 2025, and registered a low of $2.9 million during Q2 2025.